Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1439.6030.7 (+2.18 %)

PREV CLOSE ( ) 1408.90

OPEN PRICE ( ) 1419.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5987

TODAY'S LOW / HIGH ( )1406.60 1465.50

52 WK LOW / HIGH ( )890 1524.85

NSE1438.6029.3 (+2.08 %)

PREV CLOSE( ) 1409.30

OPEN PRICE ( ) 1409.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1438.60 (3)

VOLUME 177399

TODAY'S LOW / HIGH( ) 1408.00 1469.00

52 WK LOW / HIGH ( )889 1519.9

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

22698.22

21005.37

21162.45

19626.3

Total Expenditure

18306.97

16837.64

17138.45

16080.23

PBIDT (Excl OI)

4391.25

4167.73

4024

3546.07

Other Income

394.77

36.96

44.53

38.96

Operating Profit

4786.02

4204.69

4068.53

3585.03

Interest

325.42

267.55

390.25

317.78

Exceptional Items

-35

-103.78

PBDT

4460.6

3902.14

3574.5

3267.25

Depreciation

1046.43

994.56

968.37

968.06

Profit Before Tax

3414.17

2907.58

2606.13

2299.19

Tax

900.47

759.65

633.76

738.28

Provisions and contingencies

Profit After Tax

2513.7

2147.93

1972.37

1560.91

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2513.7

2147.93

1972.37

1560.91

Minority Interest

-79.06

-78.4

-82.8

-23.69

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2434.64

2069.53

1889.57

1537.22

Equity Capital

1895.65

1895.08

1894.83

1894.32

Face Value (IN RS)

Reserves

Calculated EPS

12.84

10.92

9.97

8.11

Calculated EPS (Annualised)

51.37

43.68

39.88

32.45

No of Public Share Holdings

41923389

41859065

41834065

41782565

% of Public Share Holdings

22.12

22.09

22.08

22.06

PBIDTM% (Excl OI)

19.34

19.84

19.01

18.06

PBIDTM%

21.08

20.01

19.22

18.26

PBDTM%

19.65

18.57

16.89

16.64

PBTM%

15.04

13.84

12.31

11.71

PATM%

11.07

10.22

9.32

7.95

Notes

Risk Disclosures on Derivatives

Quarterly Results

EMCURE PHARMACEUTICALS LTD.